Aquestive Therapeutics, Inc. (AQST)
4.23
+0.06
(+1.44%)
USD |
NASDAQ |
May 21, 16:00
4.23
0.00 (0.00%)
After-Hours: 19:59
Aquestive Therapeutics Research and Development Expense (TTM) : 16.04M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Nektar Therapeutics | 122.50M |
| Crinetics Pharmaceuticals, Inc. | 351.77M |
| Harrow, Inc. | 15.36M |
| MariMed, Inc. | -- |
| Journey Medical Corp. | 0.441M |